Universities and colleges
Discordant Gene Expression in Adoptively Transferred Retrovirally Modified T Cells
Adoptively transferred retrovirally modified T cells hold promise in the treatment of select cancers, but their efficacy is hindered by the persistent problem of attaining long-term and multi-gene retroviral expression in vivo. A study by M.P. Rubinstein and colleagues at the University of California found that in vitro assays